Drug shortages homepage
Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.
Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.
The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.
Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.
If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.
Below are the newest shortage and discontinuation reports and updates to existing ones.
LEGEND
!!T3 denotes an actual Tier 3 shortage/discontinuation
!T3 denotes an anticipated Tier 3 shortage/discontinuation
Shortage Reports
Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
---|---|---|---|---|---|---|
HUMULIN R | ELI LILLY CANADA INC | Actual shortage | 100UNIT | Updated Report | 2024-04-23 | 225163 |
ULTRAVIST 370 | BAYER INC | Actual shortage | 77% | Updated Report | 2024-04-23 | 218759 |
ULTRAVIST 370 | BAYER INC | Actual shortage | 77% | Updated Report | 2024-04-23 | 215787 |
SANDOZ POSACONAZOLE | SANDOZ CANADA INCORPORATED | Actual shortage | 100MG | Updated Report | 2024-04-23 | 218024 |
SANDOZ OLMESARTAN | SANDOZ CANADA INCORPORATED | Actual shortage | 20MG | Updated Report | 2024-04-23 | 223197 |
ESTALIS 250/50 MCG | SANDOZ CANADA INCORPORATED | Actual shortage | 250MCG 50MCG | Updated Report | 2024-04-23 | 216175 |
SANDOZ ZOLMITRIPTAN ODT | SANDOZ CANADA INCORPORATED | Anticipated shortage | 2.5MG | New Report | 2024-04-23 | 225976 |
SANDOZ TIMOLOL | SANDOZ CANADA INCORPORATED | Anticipated shortage | 0.25% | New Report | 2024-04-23 | 225972 |
SANDOZ LEVOFLOXACIN | SANDOZ CANADA INCORPORATED | Anticipated shortage | 250MG | New Report | 2024-04-23 | 225968 |
SANDOZ EVEROLIMUS | SANDOZ CANADA INCORPORATED | Anticipated shortage | 5MG | New Report | 2024-04-23 | 225965 |
Discontinuation Reports
Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
---|---|---|---|---|---|---|
DULOXETINE | SANIS HEALTH INC | Reversed | 30MG | Updated Report | 2024-04-23 | 219618 |
LIDOCAINE HYDROCHLORIDE INJECTION USP | HIKMA CANADA LIMITED | Discontinued | 10MG | Updated Report | 2024-04-22 | 225805 |
STRATTERA | ELI LILLY CANADA INC | To be discontinued | 18MG | Updated Report | 2024-04-19 | 171480 |
MYLAN-VERAPAMIL | MYLAN PHARMACEUTICALS ULC | Discontinued | 80MG | Updated Report | 2024-04-12 | 224846 |
TD ADSORBED | SANOFI PASTEUR LIMITED | To be discontinued | 5LF 2LF | Updated Report | 2024-04-10 | 206909 |
PEDIACEL | SANOFI PASTEUR LIMITED | To be discontinued | 5MCG 20MCG 30MCG 10MCG 32UNIT 8UNIT 40UNIT 5LF 15LF 20MCG 3MCG | Updated Report | 2024-04-10 | 206912 |
DENTICARE CHLORHEXIDINE GLUCONATE ORAL RINSE 0.12% | AMD MEDICOM INC | Discontinued | 0.12% | New Report | 2024-04-09 | 224698 |
DENTICARE CHLORHEXIDINE GLUCONATE ORAL RINSE 0.12% | AMD MEDICOM INC | Discontinued | 0.12% | Updated Report | 2024-04-09 | 224713 |
PAXIL TAB 30MG | GLAXOSMITHKLINE INC | To be discontinued | 30MG | New Report | 2024-04-05 | 224430 |
PAXIL TAB 10MG | GLAXOSMITHKLINE INC | To be discontinued | 10MG | New Report | 2024-04-05 | 224405 |
HUMALOG | ELI LILLY CANADA INC | To be discontinued | 100UNIT | New Report | 2024-04-04 | 224347 |
HUMULIN R | ELI LILLY CANADA INC | To be discontinued | 100UNIT | New Report | 2024-04-04 | 224344 |
EVUSHELD | ASTRAZENECA CANADA INC | Discontinued | 150MG 150MG | Updated Report | 2024-04-04 | 224094 |
SANDOZ OMEPRAZOLE | SANDOZ CANADA INCORPORATED | Discontinued | 20MG | Updated Report | 2024-04-04 | 224216 |
SANDOZ SENNA S | SANDOZ CANADA INCORPORATED | Discontinued | 50MG 8.6MG | Updated Report | 2024-04-03 | 224180 |
SANDOZ D-FORTE | SANDOZ CANADA INCORPORATED | Discontinued | 50000UNIT | Updated Report | 2024-04-03 | 224169 |
TEVA-IRBESARTAN | TEVA CANADA LIMITED | Discontinued | 75MG | New Report | 2024-04-01 | 224049 |
APO-CARVEDILOL | APOTEX INC | To be discontinued | 12.5MG | Updated Report | 2024-04-01 | 217493 |
THALOMID | BRISTOL-MYERS SQUIBB CANADA | Discontinued | 200MG | Updated Report | 2024-04-01 | 205531 |
FLAGYL | SANOFI-AVENTIS CANADA INC | To be discontinued | 10% | New Report | 2024-03-28 | 223877 |